

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.49290688 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.28742393 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25817280 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.18850867 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 5.10130354 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.76630724 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76630724 |
| 8 | response to muramyl dipeptide (GO:0032495) | 4.60851732 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.43489728 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43489728 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43489728 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43489728 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.43489728 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43489728 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.37240468 |
| 16 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.33269922 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.18930891 |
| 18 | response to peptidoglycan (GO:0032494) | 4.04386176 |
| 19 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.04247022 |
| 20 | myeloid dendritic cell differentiation (GO:0043011) | 3.96814444 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.93291752 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 3.91803144 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.89468247 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.89468247 |
| 25 | response to type I interferon (GO:0034340) | 3.88192033 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 3.86678928 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86189898 |
| 28 | positive regulation of interleukin-12 production (GO:0032735) | 3.85189412 |
| 29 | myeloid dendritic cell activation (GO:0001773) | 3.75853684 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.70412747 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69487952 |
| 32 | granulocyte activation (GO:0036230) | 3.68153610 |
| 33 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.67441412 |
| 34 | neutrophil activation (GO:0042119) | 3.66441861 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65233237 |
| 36 | defense response to protozoan (GO:0042832) | 3.63706797 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.55305404 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.54044980 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.52728125 |
| 40 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.49946489 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.48920659 |
| 42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.45987331 |
| 43 | leukocyte aggregation (GO:0070486) | 3.45471298 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.45233214 |
| 45 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.44873812 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44752351 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44503022 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.42977864 |
| 49 | regulation of vitamin metabolic process (GO:0030656) | 3.41012619 |
| 50 | germinal center formation (GO:0002467) | 3.40677999 |
| 51 | regulation of podosome assembly (GO:0071801) | 3.40635233 |
| 52 | respiratory burst (GO:0045730) | 3.38158822 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.35203456 |
| 54 | T cell migration (GO:0072678) | 3.35014880 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.33751773 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.32133065 |
| 57 | detection of other organism (GO:0098543) | 3.31759448 |
| 58 | regulation of interleukin-12 production (GO:0032655) | 3.31609680 |
| 59 | response to protozoan (GO:0001562) | 3.28173868 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.28014309 |
| 61 | detection of bacterium (GO:0016045) | 3.25136989 |
| 62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25085876 |
| 63 | positive regulation of heat generation (GO:0031652) | 3.24993499 |
| 64 | B cell mediated immunity (GO:0019724) | 3.22646091 |
| 65 | regulation of chemokine biosynthetic process (GO:0045073) | 3.21438266 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.18721090 |
| 67 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.18304299 |
| 68 | natural killer cell mediated immunity (GO:0002228) | 3.18304299 |
| 69 | regulation of mononuclear cell migration (GO:0071675) | 3.18047349 |
| 70 | positive regulation of humoral immune response (GO:0002922) | 3.16087352 |
| 71 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.15290353 |
| 72 | cellular response to zinc ion (GO:0071294) | 3.14783431 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 3.13877071 |
| 74 | positive regulation of interleukin-2 production (GO:0032743) | 3.13748003 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 3.13605669 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13580271 |
| 77 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.12379516 |
| 78 | mature B cell differentiation (GO:0002335) | 3.11939168 |
| 79 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.10992056 |
| 80 | dendritic cell differentiation (GO:0097028) | 3.10236056 |
| 81 | positive thymic T cell selection (GO:0045059) | 3.09291690 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08499064 |
| 83 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08432198 |
| 84 | activation of MAPKKK activity (GO:0000185) | 3.07800624 |
| 85 | negative thymic T cell selection (GO:0045060) | 3.07586072 |
| 86 | T-helper 1 type immune response (GO:0042088) | 3.07472948 |
| 87 | response to interferon-beta (GO:0035456) | 3.05246480 |
| 88 | regulation of fever generation (GO:0031620) | 3.03512142 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.03223348 |
| 90 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.02847134 |
| 91 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.02406823 |
| 92 | negative regulation of cell killing (GO:0031342) | 3.02190740 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02190740 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 3.01295026 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 3.01258348 |
| 96 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.99255235 |
| 97 | negative T cell selection (GO:0043383) | 2.96963108 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 2.96755971 |
| 99 | response to host immune response (GO:0052572) | 2.96485352 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96485352 |
| 101 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96307880 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96224682 |
| 103 | glycosphingolipid catabolic process (GO:0046479) | 2.96222821 |
| 104 | response to interferon-gamma (GO:0034341) | 2.96002731 |
| 105 | tolerance induction (GO:0002507) | 2.95099966 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.94871433 |
| 107 | cellular response to interferon-gamma (GO:0071346) | 2.94592258 |
| 108 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92705114 |
| 109 | detection of external biotic stimulus (GO:0098581) | 2.89672455 |
| 110 | monocyte chemotaxis (GO:0002548) | 2.88046871 |
| 111 | cellular response to lipopolysaccharide (GO:0071222) | 2.87787727 |
| 112 | leukocyte cell-cell adhesion (GO:0007159) | 2.87683803 |
| 113 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.87451527 |
| 114 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86364073 |
| 115 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84700954 |
| 116 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.84615638 |
| 117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84131989 |
| 118 | oligosaccharide catabolic process (GO:0009313) | 2.83692826 |
| 119 | positive regulation of interleukin-17 production (GO:0032740) | 2.82215816 |
| 120 | regulation of interleukin-17 production (GO:0032660) | 2.82172315 |
| 121 | cellular response to molecule of bacterial origin (GO:0071219) | 2.82024460 |
| 122 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.81534405 |
| 123 | myeloid leukocyte activation (GO:0002274) | 2.80403187 |
| 124 | cellular response to exogenous dsRNA (GO:0071360) | 2.80202768 |
| 125 | cytokine secretion (GO:0050663) | 2.79711210 |
| 126 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.78999337 |
| 127 | macrophage activation (GO:0042116) | 2.78967447 |
| 128 | positive regulation of isotype switching (GO:0045830) | 2.78967017 |
| 129 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.78538994 |
| 130 | response to host (GO:0075136) | 2.78366376 |
| 131 | response to host defenses (GO:0052200) | 2.78366376 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78366376 |
| 133 | cellular extravasation (GO:0045123) | 2.78221775 |
| 134 | positive regulation of B cell mediated immunity (GO:0002714) | 2.77804784 |
| 135 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.77804784 |
| 136 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.75238479 |
| 137 | positive regulation of interleukin-10 production (GO:0032733) | 2.74754549 |
| 138 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72381570 |
| 139 | regulation of T-helper cell differentiation (GO:0045622) | 2.72267830 |
| 140 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70396169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.71683114 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.65587746 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.76321530 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.68804032 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.48279215 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.22103944 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.04938644 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.84226483 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.67069682 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63199191 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42951584 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22808232 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.20339603 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.17254737 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.04496555 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99432907 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84499150 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79844789 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49205185 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.40420630 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34493215 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33946904 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.23598070 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.21626368 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17668564 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.16823193 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16778298 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13776011 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10608009 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10596826 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10564337 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.02340520 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00899573 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96398249 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86001950 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84309173 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73719380 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68892222 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67120977 |
| 40 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.64636928 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63973429 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62235735 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61891721 |
| 44 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48751817 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48158624 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47748540 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47295780 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46258317 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46055072 |
| 50 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43530326 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38107441 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38025315 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33937938 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.30584264 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29794216 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29409541 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26191500 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24207712 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23672408 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22764559 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22312550 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22065303 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17143622 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16952677 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16350371 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13536724 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11843137 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11455808 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11056608 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10979666 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10752120 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10414543 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08044220 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07503978 |
| 75 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07247869 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07051949 |
| 77 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05162002 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03721757 |
| 79 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03527145 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03306295 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02643977 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02610204 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02080199 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00951631 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98550932 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96999826 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96672546 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92665072 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89970443 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88937286 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88869808 |
| 92 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87121772 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86404565 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86060076 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85878078 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83978445 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82851426 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82559172 |
| 99 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81537900 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80983561 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80761351 |
| 102 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.80497552 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74216670 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74086952 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71633799 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.71474079 |
| 107 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.67669076 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.66423252 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.65748871 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64858279 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64293840 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63536152 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.63258868 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.63258868 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62081725 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60960418 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60547704 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60227884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.01120339 |
| 2 | MP0000685_abnormal_immune_system | 3.91481062 |
| 3 | MP0009785_altered_susceptibility_to | 3.65585017 |
| 4 | MP0003436_decreased_susceptibility_to | 3.57259293 |
| 5 | MP0005387_immune_system_phenotype | 3.43268150 |
| 6 | MP0001790_abnormal_immune_system | 3.43268150 |
| 7 | MP0005671_abnormal_response_to | 3.30705549 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.30059069 |
| 9 | MP0004510_myositis | 3.17155320 |
| 10 | MP0003303_peritoneal_inflammation | 3.17141346 |
| 11 | * MP0001800_abnormal_humoral_immune | 3.16732514 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 3.13864094 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.92253500 |
| 14 | MP0005025_abnormal_response_to | 2.88899437 |
| 15 | MP0002419_abnormal_innate_immunity | 2.83975515 |
| 16 | * MP0002723_abnormal_immune_serum | 2.80329150 |
| 17 | * MP0001819_abnormal_immune_cell | 2.53987077 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.53274770 |
| 19 | MP0003724_increased_susceptibility_to | 2.45633823 |
| 20 | MP0006082_CNS_inflammation | 2.38221156 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.31049817 |
| 22 | MP0001853_heart_inflammation | 2.25376826 |
| 23 | MP0002405_respiratory_system_inflammati | 2.22077098 |
| 24 | MP0004947_skin_inflammation | 2.10551684 |
| 25 | MP0002254_reproductive_system_inflammat | 2.04122502 |
| 26 | * MP0002398_abnormal_bone_marrow | 2.03858594 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.02273603 |
| 28 | * MP0000716_abnormal_immune_system | 2.00725393 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.00441372 |
| 30 | MP0005451_abnormal_body_composition | 1.96913309 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.93338212 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.90236183 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.88371480 |
| 34 | MP0001873_stomach_inflammation | 1.87491869 |
| 35 | MP0002006_tumorigenesis | 1.85514328 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.81171415 |
| 37 | MP0005310_abnormal_salivary_gland | 1.76884267 |
| 38 | MP0009278_abnormal_bone_marrow | 1.75147321 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.74019535 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.71873104 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.68021361 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.64090234 |
| 43 | * MP0002429_abnormal_blood_cell | 1.61238824 |
| 44 | MP0002722_abnormal_immune_system | 1.59441484 |
| 45 | MP0009764_decreased_sensitivity_to | 1.56023602 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.52995466 |
| 47 | MP0008469_abnormal_protein_level | 1.51651840 |
| 48 | MP0003448_altered_tumor_morphology | 1.46913100 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.46295878 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.46295878 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.31931560 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.26731196 |
| 53 | MP0000343_altered_response_to | 1.21945821 |
| 54 | MP0008004_abnormal_stomach_pH | 1.20309528 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.19656084 |
| 56 | MP0000858_altered_metastatic_potential | 1.19476448 |
| 57 | MP0002933_joint_inflammation | 1.19112550 |
| 58 | MP0003866_abnormal_defecation | 1.18492386 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.17608321 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.16408255 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.15501297 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.14135954 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.14097063 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.10130729 |
| 65 | MP0003075_altered_response_to | 1.05116259 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.02474237 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.00451536 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.99955679 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.99758188 |
| 70 | MP0001851_eye_inflammation | 0.97661971 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.95909226 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.95302299 |
| 73 | MP0010307_abnormal_tumor_latency | 0.91153548 |
| 74 | MP0000604_amyloidosis | 0.91021788 |
| 75 | MP0003690_abnormal_glial_cell | 0.90501057 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.89493714 |
| 77 | MP0005166_decreased_susceptibility_to | 0.89143619 |
| 78 | MP0003828_pulmonary_edema | 0.88024543 |
| 79 | MP0009763_increased_sensitivity_to | 0.86709505 |
| 80 | MP0000490_abnormal_crypts_of | 0.85124609 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.85069310 |
| 82 | MP0003091_abnormal_cell_migration | 0.82142724 |
| 83 | MP0005390_skeleton_phenotype | 0.79710415 |
| 84 | MP0000249_abnormal_blood_vessel | 0.78431220 |
| 85 | MP0006054_spinal_hemorrhage | 0.77619074 |
| 86 | MP0008874_decreased_physiological_sensi | 0.76098605 |
| 87 | MP0005165_increased_susceptibility_to | 0.73913756 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.72424701 |
| 89 | MP0009840_abnormal_foam_cell | 0.69938974 |
| 90 | MP0003329_amyloid_beta_deposits | 0.68913813 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.68799633 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.68217568 |
| 93 | MP0001663_abnormal_digestive_system | 0.67144454 |
| 94 | MP0004883_abnormal_blood_vessel | 0.66496174 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.66086499 |
| 96 | MP0000371_diluted_coat_color | 0.64706208 |
| 97 | MP0005164_abnormal_response_to | 0.63808869 |
| 98 | MP0008057_abnormal_DNA_replication | 0.62808587 |
| 99 | MP0003045_fibrosis | 0.62064627 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.61912137 |
| 101 | MP0000920_abnormal_myelination | 0.61239480 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.57926321 |
| 103 | MP0005647_abnormal_sex_gland | 0.56826445 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.56598450 |
| 105 | MP0003795_abnormal_bone_structure | 0.56083588 |
| 106 | MP0003195_calcinosis | 0.53322724 |
| 107 | MP0005023_abnormal_wound_healing | 0.52832569 |
| 108 | MP0001542_abnormal_bone_strength | 0.51816043 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.50791648 |
| 110 | MP0008260_abnormal_autophagy | 0.50643674 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.50620537 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.49907259 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.49736078 |
| 114 | MP0000609_abnormal_liver_physiology | 0.47794852 |
| 115 | MP0001191_abnormal_skin_condition | 0.47327310 |
| 116 | MP0001881_abnormal_mammary_gland | 0.44587526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.05502785 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.01378417 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.95303338 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.95303338 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.95303338 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.74757025 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.55620876 |
| 8 | Myositis (HP:0100614) | 5.02683072 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.71232168 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.67453003 |
| 11 | Optic neuritis (HP:0100653) | 4.50810288 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.50810288 |
| 13 | Orchitis (HP:0100796) | 4.49699132 |
| 14 | Stomatitis (HP:0010280) | 4.35252984 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.31852939 |
| 16 | Recurrent viral infections (HP:0004429) | 4.31473588 |
| 17 | Recurrent skin infections (HP:0001581) | 4.25448752 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.24732613 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 4.24732613 |
| 20 | Abnormality of macrophages (HP:0004311) | 4.12238212 |
| 21 | Vasculitis (HP:0002633) | 4.08051582 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.89120686 |
| 23 | Chronic otitis media (HP:0000389) | 3.88216641 |
| 24 | Loss of speech (HP:0002371) | 3.87696223 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.83083483 |
| 26 | Disinhibition (HP:0000734) | 3.68457311 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.65968226 |
| 28 | Cellulitis (HP:0100658) | 3.64456963 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61157401 |
| 30 | Meningitis (HP:0001287) | 3.57978239 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.47769416 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.47328985 |
| 33 | Colitis (HP:0002583) | 3.46561023 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.36090832 |
| 35 | Obstructive lung disease (HP:0006536) | 3.35741062 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.35741062 |
| 37 | Gingivitis (HP:0000230) | 3.32795189 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.26293868 |
| 39 | Increased IgM level (HP:0003496) | 3.22492243 |
| 40 | Nasal polyposis (HP:0100582) | 3.20967605 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 3.16289363 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 3.16179827 |
| 43 | Pustule (HP:0200039) | 3.15214666 |
| 44 | Abnormality of T cell number (HP:0011839) | 3.13060433 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.09041343 |
| 46 | Leukocytosis (HP:0001974) | 3.02217295 |
| 47 | Mutism (HP:0002300) | 3.01868981 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.94239396 |
| 49 | T lymphocytopenia (HP:0005403) | 2.94224127 |
| 50 | Arterial thrombosis (HP:0004420) | 2.92697979 |
| 51 | Hematochezia (HP:0002573) | 2.91733178 |
| 52 | Osteomyelitis (HP:0002754) | 2.91560470 |
| 53 | Abnormality of T cells (HP:0002843) | 2.89129911 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.87779827 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.86316222 |
| 56 | Increased serum ferritin (HP:0003281) | 2.75400961 |
| 57 | Periodontitis (HP:0000704) | 2.74282651 |
| 58 | Thyroiditis (HP:0100646) | 2.73783190 |
| 59 | Glomerulonephritis (HP:0000099) | 2.72739202 |
| 60 | IgM deficiency (HP:0002850) | 2.72671619 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.72582815 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72135481 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.70834524 |
| 64 | Hemoptysis (HP:0002105) | 2.69816550 |
| 65 | Eosinophilia (HP:0001880) | 2.68522891 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68012225 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68012225 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68012225 |
| 69 | Emphysema (HP:0002097) | 2.65622961 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.65205944 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.62684252 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.61432401 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.58927843 |
| 74 | Thrombocytosis (HP:0001894) | 2.58729106 |
| 75 | Urticaria (HP:0001025) | 2.57127562 |
| 76 | Axonal loss (HP:0003447) | 2.56361376 |
| 77 | Lymphopenia (HP:0001888) | 2.56155623 |
| 78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54658623 |
| 79 | Purpura (HP:0000979) | 2.54434807 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.53025166 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.49239894 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49239894 |
| 83 | Nuclear cataract (HP:0100018) | 2.47829056 |
| 84 | Encephalitis (HP:0002383) | 2.47261135 |
| 85 | IgG deficiency (HP:0004315) | 2.46381460 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.45036589 |
| 87 | Neurofibrillary tangles (HP:0002185) | 2.42706371 |
| 88 | Increased IgE level (HP:0003212) | 2.41635350 |
| 89 | Apathy (HP:0000741) | 2.40407906 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 2.37046049 |
| 91 | Upper motor neuron abnormality (HP:0002127) | 2.36802228 |
| 92 | Diminished motivation (HP:0000745) | 2.36479946 |
| 93 | Gingival bleeding (HP:0000225) | 2.35539905 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.35496977 |
| 95 | Hypertensive crisis (HP:0100735) | 2.33982003 |
| 96 | Chronic sinusitis (HP:0011109) | 2.31736428 |
| 97 | Chronic diarrhea (HP:0002028) | 2.30487960 |
| 98 | IgA deficiency (HP:0002720) | 2.28484487 |
| 99 | Gangrene (HP:0100758) | 2.28235903 |
| 100 | Severe combined immunodeficiency (HP:0004430) | 2.26099547 |
| 101 | Granulocytopenia (HP:0001913) | 2.25978979 |
| 102 | Hepatosplenomegaly (HP:0001433) | 2.25211667 |
| 103 | Combined immunodeficiency (HP:0005387) | 2.24971191 |
| 104 | Amyloidosis (HP:0011034) | 2.24379362 |
| 105 | Personality changes (HP:0000751) | 2.22919974 |
| 106 | Prostate neoplasm (HP:0100787) | 2.22120166 |
| 107 | Increased cerebral lipofuscin (HP:0011813) | 2.20330649 |
| 108 | B lymphocytopenia (HP:0010976) | 2.19980338 |
| 109 | Abnormality of B cell number (HP:0010975) | 2.19980338 |
| 110 | Premature loss of primary teeth (HP:0006323) | 2.19646492 |
| 111 | Arthralgia (HP:0002829) | 2.19489323 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.19153704 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18072547 |
| 114 | Skin ulcer (HP:0200042) | 2.16827020 |
| 115 | Restrictive lung disease (HP:0002091) | 2.16631698 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 2.15822818 |
| 117 | Myocardial infarction (HP:0001658) | 2.15454019 |
| 118 | Thick nail (HP:0001805) | 2.14841769 |
| 119 | Polyneuropathy (HP:0001271) | 2.14356358 |
| 120 | Tetraparesis (HP:0002273) | 2.14031416 |
| 121 | Sepsis (HP:0100806) | 2.12029147 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 2.09712654 |
| 123 | Recurrent sinusitis (HP:0011108) | 2.09553764 |
| 124 | Joint swelling (HP:0001386) | 2.08534302 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06970598 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 2.06431197 |
| 127 | Agnosia (HP:0010524) | 2.03937339 |
| 128 | Chest pain (HP:0100749) | 2.03557983 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.02574662 |
| 130 | Petechiae (HP:0000967) | 2.01841287 |
| 131 | Abnormality of the fingertips (HP:0001211) | 2.01638160 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.96729782 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.95501850 |
| 134 | Papilloma (HP:0012740) | 1.94090701 |
| 135 | Verrucae (HP:0200043) | 1.94090701 |
| 136 | Anorexia (HP:0002039) | 1.89499006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.98906555 |
| 2 | MAP4K1 | 3.98824226 |
| 3 | TBK1 | 3.65736318 |
| 4 | IRAK3 | 3.21773331 |
| 5 | RIPK4 | 3.20758257 |
| 6 | TYK2 | 3.16428736 |
| 7 | PRPF4B | 3.07288302 |
| 8 | JAK3 | 2.97581413 |
| 9 | IKBKE | 2.92742234 |
| 10 | IKBKB | 2.80048299 |
| 11 | BLK | 2.69785294 |
| 12 | TXK | 2.63888570 |
| 13 | IRAK4 | 2.55931867 |
| 14 | TAOK2 | 2.41112893 |
| 15 | JAK1 | 2.25599700 |
| 16 | MAP3K13 | 2.19621759 |
| 17 | KIT | 2.15781718 |
| 18 | CHUK | 2.05547572 |
| 19 | DDR2 | 1.97612977 |
| 20 | ERN1 | 1.88870688 |
| 21 | ZAP70 | 1.84305086 |
| 22 | GRK7 | 1.81890073 |
| 23 | BTK | 1.71396541 |
| 24 | SYK | 1.70191918 |
| 25 | TAOK1 | 1.67720227 |
| 26 | MAP3K10 | 1.63014522 |
| 27 | CSF1R | 1.58706977 |
| 28 | TAOK3 | 1.58120620 |
| 29 | EPHB1 | 1.50779579 |
| 30 | RPS6KA4 | 1.45313981 |
| 31 | CSK | 1.45205718 |
| 32 | MAP3K3 | 1.44249898 |
| 33 | TEC | 1.43609683 |
| 34 | PIM1 | 1.34222291 |
| 35 | MST4 | 1.33186623 |
| 36 | CDC42BPA | 1.32045174 |
| 37 | HCK | 1.31166326 |
| 38 | STK10 | 1.29927581 |
| 39 | FGFR4 | 1.29468471 |
| 40 | LCK | 1.25434305 |
| 41 | GRK6 | 1.24527523 |
| 42 | FGFR3 | 1.20928498 |
| 43 | TGFBR2 | 1.20577110 |
| 44 | SIK2 | 1.17951998 |
| 45 | ITK | 1.15758813 |
| 46 | FLT3 | 1.14126400 |
| 47 | PIM2 | 1.12134681 |
| 48 | LYN | 1.11259571 |
| 49 | SMG1 | 1.07487874 |
| 50 | NME2 | 1.07420752 |
| 51 | ARAF | 1.06184392 |
| 52 | JAK2 | 1.02456309 |
| 53 | CLK1 | 1.01200124 |
| 54 | SIK3 | 0.99438209 |
| 55 | TESK2 | 0.98902134 |
| 56 | EPHA3 | 0.95523015 |
| 57 | MARK3 | 0.93608192 |
| 58 | NLK | 0.91785904 |
| 59 | LRRK2 | 0.88609903 |
| 60 | MATK | 0.86121726 |
| 61 | MAP2K3 | 0.80857009 |
| 62 | BMPR2 | 0.77435339 |
| 63 | FES | 0.73863163 |
| 64 | PTK6 | 0.72218790 |
| 65 | NEK9 | 0.65224951 |
| 66 | CDK12 | 0.63130057 |
| 67 | EIF2AK2 | 0.60736307 |
| 68 | FGR | 0.57911465 |
| 69 | IRAK1 | 0.57646644 |
| 70 | PBK | 0.57464397 |
| 71 | BMX | 0.57045299 |
| 72 | KDR | 0.56746930 |
| 73 | TNK2 | 0.55739849 |
| 74 | STK4 | 0.54377765 |
| 75 | PRKCQ | 0.53225059 |
| 76 | TYRO3 | 0.51060847 |
| 77 | PDPK1 | 0.50967107 |
| 78 | ABL1 | 0.49779464 |
| 79 | MAP3K8 | 0.49603009 |
| 80 | CAMK1D | 0.48442477 |
| 81 | RPS6KC1 | 0.47704649 |
| 82 | RPS6KL1 | 0.47704649 |
| 83 | EGFR | 0.47125967 |
| 84 | ICK | 0.46792796 |
| 85 | MAPK7 | 0.46523307 |
| 86 | STK24 | 0.45683084 |
| 87 | PRKCD | 0.44970490 |
| 88 | MAPKAPK2 | 0.44399042 |
| 89 | MAP3K11 | 0.44093344 |
| 90 | DAPK3 | 0.42473667 |
| 91 | RPS6KA5 | 0.42285417 |
| 92 | MAP3K5 | 0.38148202 |
| 93 | BRAF | 0.38061617 |
| 94 | EEF2K | 0.37951188 |
| 95 | CAMKK2 | 0.37811272 |
| 96 | MAP3K9 | 0.37443808 |
| 97 | ACVR1B | 0.36924382 |
| 98 | MAPK11 | 0.36675082 |
| 99 | MAPK12 | 0.36581947 |
| 100 | ADRBK2 | 0.32416639 |
| 101 | RPS6KA2 | 0.32279253 |
| 102 | TGFBR1 | 0.31442042 |
| 103 | CDK4 | 0.31413426 |
| 104 | KSR2 | 0.31109865 |
| 105 | RPS6KA6 | 0.30629024 |
| 106 | MAP2K6 | 0.30073203 |
| 107 | ALK | 0.29994945 |
| 108 | MELK | 0.29714513 |
| 109 | MAP3K1 | 0.29442632 |
| 110 | TRPM7 | 0.29440810 |
| 111 | HIPK2 | 0.28822914 |
| 112 | PDGFRB | 0.28240742 |
| 113 | PRKD2 | 0.28008568 |
| 114 | TRIB3 | 0.27106563 |
| 115 | MARK2 | 0.26268441 |
| 116 | PDK1 | 0.26126663 |
| 117 | TLK1 | 0.25923723 |
| 118 | SCYL2 | 0.25728277 |
| 119 | SIK1 | 0.25292271 |
| 120 | INSR | 0.25262710 |
| 121 | RIPK1 | 0.24053459 |
| 122 | RPS6KA1 | 0.23940376 |
| 123 | MAP3K7 | 0.23403821 |
| 124 | CDK9 | 0.22605136 |
| 125 | FYN | 0.21629186 |
| 126 | YES1 | 0.20501837 |
| 127 | MOS | 0.17556172 |
| 128 | MAPK3 | 0.17490564 |
| 129 | IRAK2 | 0.16925441 |
| 130 | ABL2 | 0.16850933 |
| 131 | CDK6 | 0.15820155 |
| 132 | MAPK4 | 0.15137219 |
| 133 | PKN1 | 0.14820300 |
| 134 | IGF1R | 0.13243793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.27163162 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.23797131 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.78661370 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72025716 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.66675103 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63794036 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57290444 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.52525761 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.50861646 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.37195463 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35841925 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34251819 |
| 13 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29306299 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.27937594 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.25977126 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10858298 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10330622 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.95926907 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.92436642 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.87303464 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.84701479 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79781006 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79529495 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79283164 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76489781 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72627033 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.72523209 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60380415 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.59100549 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58801772 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58189032 |
| 32 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53152410 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.52874142 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50917897 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50565846 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45509933 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.42178595 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.39509191 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38233653 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26141090 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.24971382 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20304252 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16502525 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14298331 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12061242 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.08112822 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99480449 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97935227 |
| 49 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97871178 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97861924 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96849040 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.96568762 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.90057179 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.83957307 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78984298 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77142381 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76145700 |
| 58 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72497109 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72267018 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72199150 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68502666 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.66921675 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66806153 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65654521 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65534299 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.64582371 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59638302 |
| 68 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54342659 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51233666 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49207965 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48816596 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48256129 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48046075 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46357196 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45572499 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.44216883 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43321741 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41366305 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39528165 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36766768 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36466426 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36398410 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35683846 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34199177 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33950722 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31665087 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.29621042 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29306099 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28971499 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28483848 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27767596 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26470686 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.24669507 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24386027 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22394648 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20627004 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20473950 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19800752 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19206632 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.19063133 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18832799 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17708560 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17522721 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16928703 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.16090371 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15188144 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15058368 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13656227 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13603235 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | 0.12358129 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11592278 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11186432 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10180134 |

